Valsartan and Similar Hypertension Drugs Had No Effect On COVID-19 Survival: Study
A new study questions whether hypertension drugs have a negative impact on patients with COVID-19 infections.
A new study questions whether hypertension drugs have a negative impact on patients with COVID-19 infections.
A new study finds that valsartan and similar drugs do not increase the risk of poor outcomes from COVID-19.
New study questions whether hypertension drugs increase severity of COVID-19.
Some researcher warn that blood pressure medications like valsartan and Benicar could increase the severity and lethality of the coronavirus.
A status conference on Wednesday will discuss how to move valsartan litigation forward with short form complaints and plaintiffs fact sheets.
The attorney overseeing all valsartan recall lawsuits has appointed attorneys to various leadership roles in the consolidated litigation over tainted generic blood pressure medications.
Thousands of valsartan lawsuits may be filed over the coming two years as the recalls expand and more plaintiffs link their cancer cases to use of the tainted drugs.
A federal judge is expected to select attorneys for leadership positions in valsartan recall litigation by the end of the month.
Plaintiffs can now file valsartan recall lawsuits over cancer injuries directly with the MDL court in New Jersey
The FDA is providing a list of 40 blood pressure medications it says are free of cancer-causing impurities, but warns that shortages will increase beyond valsartan.